TDC
BLUE

Thompson Davis & Co’s bluebird bio BLUE Stock Holding History

Thompson Davis & Co’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-3
Closed -$1K – 1062
2016
Q1 		$1K Hold
3
– – ﹤0.01% 996
2015
Q4 		$2K Hold
3
– – ﹤0.01% 1006
2015
Q3 		$3K Hold
3
– – ﹤0.01% 929
2015
Q2 		$6K Hold
3
– – 0.01% 845
2015
Q1 		$4K Hold
3
– – ﹤0.01% 937
2014
Q4 		$3K Sell
3
-131
-98% -$87.5K ﹤0.01% 1035
2014
Q3 		$62K Sell
134
-299
-69% -$138K 0.08% 235
2014
Q2 		$216K Buy
+433
New +$139K 0.31% 85

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Thompson Davis & Co's BLUE Position: Q2 2016 in Review

Thompson Davis & Co sold out of bluebird bio (BLUE) in Q2 2016, closing a stake of 3 shares — an estimated $1K sold.

Thompson Davis & Co first reported a position in BLUE in Q2 2014 and held it in 8 quarters. The position peaked at $216K in Q2 2014. 177 funds tracked by Wall St. Rank hold BLUE as of Q2 2016.

  • Thompson Davis & Co reported no remaining bluebird bio position as of Q2 2016 after selling out during the quarter.
  • Thompson Davis & Co sold 3 bluebird bio shares in Q2 2016, an estimated $1K.
  • Thompson Davis & Co first reported a position in bluebird bio in Q2 2014 and held it in 8 quarters.
  • Thompson Davis & Co's bluebird bio position peaked at $216K in Q2 2014.
  • 177 funds tracked by Wall St. Rank held bluebird bio as of Q2 2016.

Based on Thompson Davis & Co's 13F filing for Q2 2016, filed 9 Aug 2016.